New Zealand markets open in 45 minutes

Dyne Therapeutics, Inc. (DYN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
27.68-1.07 (-3.72%)
At close: 04:00PM EDT
27.76 +0.08 (+0.29%)
After hours: 07:43PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-257,399
-235,937
-168,099
-149,291
-59,437
Depreciation & amortisation
1,647
1,673
1,683
1,088
700
Stock-based compensation
35,261
19,972
15,178
17,542
6,591
Change in working capital
1,400
26,307
-5,379
9,256
5,112
Accounts payable
743
22,970
-1,235
13,702
8,567
Other working capital
-220,477
-188,887
-156,712
-123,181
-47,669
Other non-cash items
750
788
1,662
-746
514
Net cash provided by operating activities
-219,787
-188,158
-153,645
-119,563
-46,508
Cash flows from investing activities
Investments in property, plant and equipment
-690
-729
-3,067
-3,618
-1,161
Purchases of investments
-208,961
-44,262
-121,176
-236,721
-44,500
Sales/maturities of investments
86,063
128,302
211,445
102,447
0
Other investing activities
-
-
-
-
-44,500
Net cash used for investing activities
-123,588
83,311
87,202
-137,892
-45,661
Cash flows from financing activities
Debt repayment
-
-
-
0
-10,000
Common stock issued
421,613
52,369
36,861
157,237
246,388
Other financing activities
-
-
-
-
-450
Net cash used provided by (used for) financing activities
433,895
54,322
37,390
157,821
380,690
Net change in cash
90,520
-50,525
-29,053
-99,634
288,521
Cash at beginning of period
183,435
174,466
203,519
303,153
14,632
Cash at end of period
273,955
123,941
174,466
203,519
303,153
Free cash flow
Operating cash flow
-219,787
-188,158
-153,645
-119,563
-46,508
Capital expenditure
-690
-729
-3,067
-3,618
-1,161
Free cash flow
-220,477
-188,887
-156,712
-123,181
-47,669